| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10158407 | Clinical Therapeutics | 2018 | 17 Pages |
Abstract
With increasing use of antiherpesviral agents for extended periods, particularly in immunocompromised hosts, the emergence of resistant viruses has necessitated the development of newer agents with novel targets and better side-effect profiles.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Claudette L. MD, Scott H. MD,